EWM
ALDX icon

Edge Wealth Management’s Aldeyra Therapeutics ALDX Stock Holding History

Edge Wealth Management’s Portfolio ALDX Stock Details ALDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-10
Closed -$1K – 521
2021
Q3 		$1K Hold
10
– – ﹤0.01% 464
2021
Q2 		$1K Hold
10
– – ﹤0.01% 394
2021
Q1 		$1K Hold
10
– – ﹤0.01% 390
2020
Q4 		$1K Buy
+10
New +$70 ﹤0.01% 338
2020
Q3 		– Sell
-1,000
Closed -$4K – 444
2020
Q2 		$4K Hold
1,000
– – ﹤0.01% 569
2020
Q1 		$2K Buy
+1,000
New +$4.5K ﹤0.01% 537

Other funds holding ALDX

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Edge Wealth Management's ALDX Position: Q4 2021 in Review

Edge Wealth Management sold out of Aldeyra Therapeutics (ALDX) in Q4 2021, closing a stake of 10 shares — an estimated $1K sold.

Edge Wealth Management first reported a position in ALDX in Q1 2020 and held it in 6 quarters. The position peaked at $4K in Q2 2020. 115 funds tracked by Wall St. Rank hold ALDX as of Q4 2021.

  • Edge Wealth Management reported no remaining Aldeyra Therapeutics position as of Q4 2021 after selling out during the quarter.
  • Edge Wealth Management sold 10 Aldeyra Therapeutics shares in Q4 2021, an estimated $1K.
  • Edge Wealth Management first reported a position in Aldeyra Therapeutics in Q1 2020 and held it in 6 quarters.
  • Edge Wealth Management's Aldeyra Therapeutics position peaked at $4K in Q2 2020.
  • 115 funds tracked by Wall St. Rank held Aldeyra Therapeutics as of Q4 2021.

Based on Edge Wealth Management's 13F filing for Q4 2021, filed 14 Jan 2022.